[ExI] glutamine and life-extension

Dave Sill sparge at gmail.com
Wed Feb 17 01:13:51 UTC 2010

On Tue, Feb 16, 2010 at 4:38 PM, Stathis Papaioannou <stathisp at gmail.com> wrote:
> On 17 February 2010 02:03, Dave Sill <sparge at gmail.com> wrote:
>> So who is motivated to research therapeutic effects of cheap
>> supplements? Drug companies are motivated by the profit potential of a
>> new, exclusive drug. There are no big payoffs in researching cheap
>> supplements.
> Medical researchers, usually publicly or not-for-profit funded.

That was sort of a rhetorical question, but since you answered it, I
have to point out that there are multiple orders of magnitude of
difference in funding between public/non-profit and for-profit. The
drug companies are frantically inventing new stuff, spending billions
on R&D. Compare that to what's spent on supplement research.

I think it's highly likely that there are effective therapeutic uses
of supplements that aren't being investigated due to lack of funding.


More information about the extropy-chat mailing list